Landscapes / Companies
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
18
in active trials · 26 in all
Trials
32 active
53 since 2021
Drugs18
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Tyrosine kinase inhibitor |
Chia Tai Tianqing Pharmaceutical Group |
Approved in China | Nov 2026soonPhase 2 trial completes | ||
| How it works | Blocks a kinase | ||||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Pancreatic Neoplasms | ||||
| Open drug page | |||||
— |
Phase 3 | Nov 2026soonPhase 2 trial completes | |||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Pancreatic Neoplasms, Metastatic Pancreatic Ductal Adenocarcinoma | ||||
| Open drug page | |||||
— |
Phase 3 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Metastatic Breast Cancer, Recurrent Breast Cancer and 4 more | ||||
| Open drug page | |||||
— |
Phase 3 | Jan 2027Phase 3 trial completes | |||
| Next date | Jan 2027 · Phase 3 trial completes | ||||
| Also tested for | Breast Cancer, Advanced Cancer and 8 more | ||||
| Open drug page | |||||
— |
Phase 3 | Aug 2027Phase 2 trial completes | |||
| Next date | Aug 2027 · Phase 2 trial completes | ||||
| Also tested for | Inflammatory Bowel Diseases, Psoriatic Arthritis and 2 more | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Hemophilia A | ||||
| Open drug page | |||||
— |
Phase 2 | Dec 2026Phase 2 trial completes | |||
| Next date | Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Non-alcoholic Steatohepatitis | ||||
| Open drug page | |||||
— |
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development |
Phase 1/2 | Dec 2026Phase 1 trial completes | ||
| Next date | Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced Cancer, RAS/BRAF Wild Type Colorectal Cancer | ||||
| Open drug page | |||||
— |
Phase 2 | 17 Mar 2027Phase 2 trial completes | |||
| Next date | 17 Mar 2027 · Phase 2 trial completes | ||||
| Also tested for | Chronic Obstructive Pulmonary Disease | ||||
| Open drug page | |||||
— |
Phase 2 | Aug 2027Phase 2 trial completes | |||
| Next date | Aug 2027 · Phase 2 trial completes | ||||
| Also tested for | Soft Tissue Sarcoma, Melanoma and 1 more | ||||
| Open drug page | |||||
— |
LaNova Medicines |
Phase 1/2 | — | ||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Chia Tai Tianqing Pharmaceutical Group |
Phase 1 | Oct 2027Phase 1 trial completes | ||
| Next date | Oct 2027 · Phase 1 trial completes | ||||
| Also tested for | Multiple Myeloma | ||||
| Open drug page | |||||
— |
Chia Tai Tianqing Pharmaceutical Group |
Phase 1 | Dec 2027Phase 1 trial completes | ||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Malignant Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Multiple Myeloma | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Breast Cancer, Lung Cancer and 2 more | ||||
| Open drug page | |||||
TQB2928not checked |
— |
Chia Tai Tianqing Pharmaceutical Group |
Phase 1 | — | |
| Also tested for | Advanced Non-small Cell Lung Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Chronic Myelogenous Leukemia | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Generalized Pustular Psoriasis | ||||
| Open drug page | |||||
No drugs match “”.
About
- No active trial
- 8 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021